The U.S. has the best medical care in the world, so people shouldn't panic over the first Ebola diagnosis in the country, an Ebola survivor said.» Read More
Health insurance premiums in the years before the rollout of the Affordable Care Act had large average increases and a high variability.
Tenet Healthcare stock is on the verge of a big breakout, Chris Verrone of Strategas Research Partners says.
Health insurers have been told that Amazon's Web Services cloud will act as a host for important enrollment data.
The CEO of ZocDoc, which allows patients to find in-network doctors and book appointments online, tells CNBC it's expanding its service.
One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
North Carolina's attorney general says GlaxoSmithKline will pay 45 states $105 million to settle claims that it unlawfully marketed drugs.
More than 2 million people who got health insurance under Obama's law have data discrepancies that could jeopardize coverage for some.
But Merck chief Kenneth Frazier also said the government needs to modify its high corporate tax code to level the playing field for American companies.
One of the nation's top privately-run Medicare insurance plans faces a federal investigation into allegations that it overbilled the government.
Former Bush administration official Josh Valdez alleges his ex-employer cheated the government out of millions annually, charges the company denies.
A Los Angeles doctor has been charged with helping bilk Medicare out of more than $33 million.
Clovis shares fell to a 52-week low Tuesday on concerns its cancer drug won't be able to compete with rival AstraZeneca.
There is market rumor and speculation that Dublin-based, U.K.-listed pharma company Shire is a takeover target.
Chicago filed a lawsuit against five pharmaceutical companies, accusing them of concealing the risks associated with certain painkillers.
CNBC pharma reporter Meg Tirrell speaks with RBC Capital Markets analyst Michael Yee at the annual ASCO conference about the big moves in drug company stocks on Monday.
In 2012, hospitals charged more for every one of 98 common ailments that could be compared to the previous year.
CNBC biotech & pharma reporter Meg Tirrell talks to Richard Pazdur, the FDA's cancer czar about how far we've come in cancer treatment, breakthrough designations and if chemotherapy will soon be a thing of the past.
Thousands of oncologists, investors, researchers and analysts descended on Chicago for the annual ASCO, the year's biggest cancer research meeting.
CNBC's Meg Tirrell and Daniel O'Day, Roche Holdings COO, discuss the latest developments in immunotherapy and treating bladder cancer.
CNBC's Meg Tirrell and Roger Perlmutter, Merck Research Laboratories president, discuss the latest data on advanced melanoma and which new drugs are in Merck's pipeline.
Get the best of CNBC in your inbox